Reduced tissue inhibitor of metalloproteinase-2 expression is associated with advanced medullary thyroid carcinoma

Simone Magagnin Wajner(Universidade Federal do Rio Grande do Sul), Ana Luiza Maia(Universidade Federal do Rio Grande do Sul)

Oncology Letters

December 19, 2013

10.3892/ol.2013.1767

Cited by 12

Related Papers

MAPK and SHH pathways modulate type 3 deiodinase expression in papillary thyroid carcinoma

|Endocrine Related Cancer|2016|37

Uncovering Actions of Type 3 Deiodinase in the Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)

|Cells|2023|13

Inflammation and Redox Homeostasis Induces Type 3 Deiodinase and Impacts Brain Endoplasmic Reticulum–Mitochondria Crosstalk Both in Local and Systemic Disease Models

|Research Square|2023|0